Alexander Khoruts

Switching from originator to biosimilar infliximab (IFX) is effective and safe. However, data on multiple switching are scarce. The Edinburgh IBD unit has undertaken three switch programmes: (1) Remicade to CT-P13 (2016), (2) CT-P13 to SB2 (2020), and (3) SB2 to CT-P13 (2021)…

INTRODUCTION: Intestinal microbiota transplantation (IMT) is an effective therapy for recurrent _Clostridioides difficile_ infection (rCDI) and a promising therapy for severe/fulminant CDI non-responsive to antibiotics…

BACKGROUND. Fecal microbiota transplantation (FMT) is recommended to prevent the recurrence of _Clostridioides difficile_ infection (CDI) following failure of antibiotic treatments alone. However, some patients do not respond to this treatment and remain refractory to repeat FMT…

SOCIETY: AGA This session will feature cutting-edge research on the multifaceted aspects of Clostridioides difficile colitis, presenting the latest findings in pathogenesis and innovative therapeutic approaches. Attendees will gain valuable insights into the molecular and immunological aspects of C…